PF4 and pulmonary fibrosis: CXCL4 can also promote the differentiation of monocytes into pro-inflammatory and pro-fibrotic DCs, potentiating the overt fibrogenesis driven by DCs, highlighting CXCL4 as a potential therapeutic target for lung fibrosis [139].